Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects
Clinical trial NCT05293171 · COMPLETED
Trial details
- NCT number
- NCT05293171
- Sponsor
- BioLineRx, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2022-06-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.